| Disease Info Index | ||||||||||||||||||||||||||
|
|
|
|
|
Text
|
Perspect Clin Res Quality of clinical trials: A moving target. Bhatt A President, Clininvent Research Pvt. Ltd., Everest Chambers, Mumbai, India. Quality of clinical trials depends on data integrity and subject protection. Globalization, outsourcing and increasing complexicity of clinical trials... Read More Source: PubMed Perspect Clin Res Survival analysis in clinical trials: Basics and must know areas. Singh R, Mukhopadhyay K Department of Community Medicine, College of Medicine and JNM Hospital, Kalyani, West Bengal, India. Many clinical trials involve following patients for a long time. The primary event of interest in those studies is death, relapse, adverse drug reacti... Read More Source: PubMed Perspect Clin Res Survival analysis in clinical trials: Basics and must know areas. Singh R, Mukhopadhyay K Department of Community Medicine, College of Medicine and JNM Hospital, Kalyani, West Bengal, India. Many clinical trials involve following patients for a long time. The primary event of interest in those studies is death, relapse, adverse drug reacti... Read More Source: PubMed PLoS ONE Pre-Clinical Assessment of Novel Multivalent MSP3 Malaria Vaccine Constructs. Bang G, Prieur E, Roussilhon C, Druilhe P Malaria Vaccine Development Laboratory, Institut Pasteur, and Vac4all initiative, Paris, France. MSP3 has been shown to induce protection against malaria in African children. The characterization of a family of Plasmodium falciparum merozoite surf... Read More Source: PubMed Front Cell Neurosci New perspectives in amblyopia therapy on adults: a critical role for the excitatory/inhibitory balance. Baroncelli L, Maffei L, Sale A Institute of Neuroscience, National Research Council Pisa, Italy. Amblyopia is the most common form of impairment of visual function affecting one eye, with a prevalence of about 1-5% of the total world population. T... Read More Source: PubMed 2011 Dec 5 Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy. Ying W, Du Z, Sun L, Foley KP, Proia DA, Blackman RK, Zhou D, Inoue T, Tatsuta N, Sang J, Ye S, Acquaviva J, Shin Ogawa L, Wada Y, Barsoum J, Koya K 1Chemistry, Synta Pharmaceuticals Corp. Targeted inhibition of the molecular chaperone heat shock protein 90 (Hsp90) results in the simultaneous blockade of multiple oncogenic signaling path... Read More Source: PubMed 2011 Dec 5 A Comparison of 3 Regimens to Prevent Nevirapine Resistance Mutations in HIV-Infected Pregnant Women Receiving a Single Intrapartum Dose of Nevirapine. Van Dyke RB, Ngo-Giang-Huong N, Shapiro DE, Frenkel L, Britto P, Roongpisuthipong A, Beck IA, Yuthavisuthi P, Prommas S, Puthanakit T, Achalapong J, Chotivanich N, Rasri W, Cressey TR, Maupin R, Mirochnick M, Jourdain G Department of Pediatrics, Tulane University Health Sciences Center. Background. Intrapartum single-dose (SD) nevirapine (NVP) reduces perinatal transmission of human immunodeficiency virus (HIV) infection but selects f... Read More Source: PubMed Am. J. Trop. Med. Hyg. Long-term albendazole effectiveness for hepatic cystic echinococcosis. Salinas JL, Gonzales HV, Astuvilca J, Arce-Villavicencio Y, Carbajal-Gonzalez D, Talledo L, Willig JH Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama; Instituto de Medicina Tropical "Daniel A. Carrión" Universidad Nacional Mayor de San Marcos, Lima, Perú; Sociedad Científica de San Fernando, Universidad Nacional Mayor de San Marcos, Lima, Perú Abstract. Little is known about the long-term effectiveness of albendazole in the medical therapy of non-complicated hepatic cystic echinococcosis (HC... Read More Source: PubMed Am. J. Trop. Med. Hyg. Nurturing the global workforce in clinical research: the national institutes of health fogarty international clinical scholars and fellows program. Heimburger DC, Carothers CL, Gardner P, Primack A, Warner TL, Vermund SH Institute for Global Health, and Fogarty International Clinical Research Scholars and Fellows Support Center at Vanderbilt University, Nashville, Tennessee; Stony Brook University School of Medicine, Stony Brook, New York; Fogarty International Center, National Institutes of Health, Bethesda, Maryland. Abstract. The Fogarty International Clinical Research Scholars and Fellows Program's goal is to foster the next generation of clinical investigators a... Read More Source: PubMed Am. J. Trop. Med. Hyg. Adaptive trial design: could we use this approach to improve clinical trials in the field of global health? Lang T Global Health Clinical Trials Programme, Centre for Tropical Medicine, University of Oxford, Oxford, United Kingdom. Abstract. We need more clinical trials in the world's poorest regions to evaluate new drugs and vaccines, and also to find better ways to manage healt... Read More Source: PubMed J Gene Med Long-term functional adeno-associated virus-microdystrophin expression in the dystrophic CXMDj dog. Koo T, Okada T, Athanasopoulos T, Foster H, Takeda S, Dickson G SWAN Institute of Biomedical and Life Sciences, School of Biological Sciences, Royal Holloway University of London, Egham, Surrey, UK. Duchenne muscular dystrophy (DMD) is a severe, inherited, muscle-wasting disorder caused by mutations in the dystrophin gene. Preclinical studies of a... Read More Source: PubMed Perspect Clin Res Quality of clinical trials: A moving target. Bhatt A President, Clininvent Research Pvt. Ltd., Everest Chambers, Mumbai, India. Quality of clinical trials depends on data integrity and subject protection. Globalization, outsourcing and increasing complexicity of clinical trials... Read More Source: PubMed PLoS ONE Pre-Clinical Assessment of Novel Multivalent MSP3 Malaria Vaccine Constructs. Bang G, Prieur E, Roussilhon C, Druilhe P Malaria Vaccine Development Laboratory, Institut Pasteur, and Vac4all initiative, Paris, France. MSP3 has been shown to induce protection against malaria in African children. The characterization of a family of Plasmodium falciparum merozoite surf... Read More Source: PubMed Front Cell Neurosci New perspectives in amblyopia therapy on adults: a critical role for the excitatory/inhibitory balance. Baroncelli L, Maffei L, Sale A Institute of Neuroscience, National Research Council Pisa, Italy. Amblyopia is the most common form of impairment of visual function affecting one eye, with a prevalence of about 1-5% of the total world population. T... Read More Source: PubMed 2011 Dec 5 Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy. Ying W, Du Z, Sun L, Foley KP, Proia DA, Blackman RK, Zhou D, Inoue T, Tatsuta N, Sang J, Ye S, Acquaviva J, Shin Ogawa L, Wada Y, Barsoum J, Koya K 1Chemistry, Synta Pharmaceuticals Corp. Targeted inhibition of the molecular chaperone heat shock protein 90 (Hsp90) results in the simultaneous blockade of multiple oncogenic signaling path... Read More Source: PubMed 2011 Dec 5 A Comparison of 3 Regimens to Prevent Nevirapine Resistance Mutations in HIV-Infected Pregnant Women Receiving a Single Intrapartum Dose of Nevirapine. Van Dyke RB, Ngo-Giang-Huong N, Shapiro DE, Frenkel L, Britto P, Roongpisuthipong A, Beck IA, Yuthavisuthi P, Prommas S, Puthanakit T, Achalapong J, Chotivanich N, Rasri W, Cressey TR, Maupin R, Mirochnick M, Jourdain G Department of Pediatrics, Tulane University Health Sciences Center. Background. Intrapartum single-dose (SD) nevirapine (NVP) reduces perinatal transmission of human immunodeficiency virus (HIV) infection but selects f... Read More Source: PubMed Am. J. Trop. Med. Hyg. Long-term albendazole effectiveness for hepatic cystic echinococcosis. Salinas JL, Gonzales HV, Astuvilca J, Arce-Villavicencio Y, Carbajal-Gonzalez D, Talledo L, Willig JH Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama; Instituto de Medicina Tropical "Daniel A. Carrión" Universidad Nacional Mayor de San Marcos, Lima, Perú; Sociedad Científica de San Fernando, Universidad Nacional Mayor de San Marcos, Lima, Perú Abstract. Little is known about the long-term effectiveness of albendazole in the medical therapy of non-complicated hepatic cystic echinococcosis (HC... Read More Source: PubMed Am. J. Trop. Med. Hyg. Nurturing the global workforce in clinical research: the national institutes of health fogarty international clinical scholars and fellows program. Heimburger DC, Carothers CL, Gardner P, Primack A, Warner TL, Vermund SH Institute for Global Health, and Fogarty International Clinical Research Scholars and Fellows Support Center at Vanderbilt University, Nashville, Tennessee; Stony Brook University School of Medicine, Stony Brook, New York; Fogarty International Center, National Institutes of Health, Bethesda, Maryland. Abstract. The Fogarty International Clinical Research Scholars and Fellows Program's goal is to foster the next generation of clinical investigators a... Read More Source: PubMed Am. J. Trop. Med. Hyg. Adaptive trial design: could we use this approach to improve clinical trials in the field of global health? Lang T Global Health Clinical Trials Programme, Centre for Tropical Medicine, University of Oxford, Oxford, United Kingdom. Abstract. We need more clinical trials in the world's poorest regions to evaluate new drugs and vaccines, and also to find better ways to manage healt... Read More Source: PubMed J Gene Med Long-term functional adeno-associated virus-microdystrophin expression in the dystrophic CXMDj dog. Koo T, Okada T, Athanasopoulos T, Foster H, Takeda S, Dickson G SWAN Institute of Biomedical and Life Sciences, School of Biological Sciences, Royal Holloway University of London, Egham, Surrey, UK. Duchenne muscular dystrophy (DMD) is a severe, inherited, muscle-wasting disorder caused by mutations in the dystrophin gene. Preclinical studies of a... Read More Source: PubMed |
| Share it! |
|
|
|
|




|
Posted by:
galbotrix
Posted on: 10/17/2011 Hello
I’m the son of a Cancer patient. I’ve 2 boxes of Inj Iscador available for cancer treatment which I could not use for my father. Iscador is a recognized therapy for Cancer treatment to balance the side effects of Chemo and other standard treatment options. Researched and manufactured in Europe, the Injections are normally prescribed by most Cancer specialist Homeopaths and a few Oncologists. These injections have to be taken regularly over a period of 2-3 months for the desired effects. But one can consult a fellow Homeopath for the exact medications. In India, these inj have to be imported from Waleda and are available only at a few select places.
The available medications are 2 boxes each of Iscador Q Series 0 and 1 @ Rs. 4500/- per box. Please read : http://www.iscador.com for more details. Also consult Dr. Kasad [Mumbai] or Dr. Navneet Rastogi (Delhi) for more info.
Mail me : sniphadkar@gmail.com for more details
Reply |
Forward
Posted by:
delmon54
Posted on: 12/31/2009 I want to start a cancer support group here at a village near Madurai, to conduct free medical check-ups, guide cancer patients like where they to go for treatment, whom to contact, how to go there, where they can get free treatment or where assistance could be got etc. Those who are already doing this kind of help to cancer patients can please guide me how to run a similar cancer support group in this village near Madurai. Please contact Gurumoorthi, thanks.
Posted by:
guest
Posted on: 09/17/2008 We are a group of anti- cancer healers and counsellors , our mission being , allow the fullest co-operation of the patient with the Specialists/Physicians for reducing the side-effects, reduce pains , ease digestion etc. All that we need is a photogragh of the patient and theh details of treatments and updations to our mail i d. Don belive us until you see the effects of our hard work . 'Service to patients with big C is service to God ' our motto . |
|
|
| Related Links | ||||||||||
|
| Citing this Health Article | ||||||
|
||||||
| News on Clinical Trials |